Preoperative Chemotherapy and Radiotherapy Concomitant to Cetuximab in Non-Small Cell Lung Cancer (NSCLC) Patients With IIIB Disease - A Multicenter Phase II Trial.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 12 Sep 2017 Results presented at the 42nd European Society for Medical Oncology Congress
- 27 Nov 2012 Planned end date changed from 1 Mar 2013 to 1 Jun 2016 as reported by ClinicalTrials.gov.
- 06 Feb 2010 New trial record